Androgen receptor signaling inhibitors linked to increased risk of cardiovascular adverse events in prostate cancer

被引：0
|
作者：
Nierengarten, Mary Beth
机构：
来源：
CANCER | 2024年 / 130卷 / 20期
关键词：
D O I：
10.1002/cncr.35555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis
    Matsukawa, Akihiro
    Yanagisawa, Takafumi
    Parizi, Mehdi Kardoust
    Laukhtina, Ekaterina
    Klemm, Jakob
    Fazekas, Tamas
    Mori, Keiichiro
    Kimura, Shoji
    Briganti, Alberto
    Ploussard, Guillaume
    Karakiewicz, Pierre I.
    Miki, Jun
    Kimura, Takahiro
    Rajwa, Pawel
    Shariat, Shahrokh F.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [22] Androgen receptor signaling in androgen-refractory prostate cancer
    Grossmann, ME
    Huang, HJ
    Tindall, DJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22): : 1687 - 1697
  • [23] JAK inhibitors: risk of major adverse cardiovascular events
    Reactions Weekly, 2025, 2052 (1) : 8 - 8
  • [24] Catalytic topoisomerase II inhibitors suppress the androgen receptor signaling and prostate cancer progression
    Li, Haolong
    Xie, Ning
    Gleave, Martin
    Dong, Xuesen
    CANCER RESEARCH, 2015, 75
  • [25] Risk of Cardiovascular Events Amongst Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
    Carelli, Eric
    Hulten, Edward
    Dragomir, Alice
    Boulet, Jacinthe
    Nadeau, Lyne
    Brophy, Jay
    Mousavi, Negar
    CIRCULATION, 2017, 136
  • [26] Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide
    Wang, Qi
    Ren, Zhao-Ting
    Wu, Hui-Feng
    Gu, Hao-Chen
    Li, Xia-Wei
    Tang, Zhuang-Li
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [27] Glucocorticoids mediate adverse events of deep androgen receptor axis inhibition in prostate cancer patients
    Kaochar, S.
    Mitsiades, N.
    ANNALS OF ONCOLOGY, 2020, 31 (03) : 323 - 325
  • [28] Major adverse cardiovascular events after androgen deprivation therapy in patients with prostate cancer with hypercholesterolemia.
    Twardowski, Przemyslaw
    Henry, Jacqueline
    Atkinson, Stuart
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [29] MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER PATIENTS WITH HYPERCHOLESTEROLEMIA/DIABETES
    Torres, Lindsay
    Boldt-Houle, Deborah
    Atkinson, Stuart
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [30] Androgen deprivation therapy with agonists of GnRH: cardiovascular adverse events and comorbidity considerations in patients with prostate cancer
    Gritskevich, E. Y. U.
    Demidova, T. Y. U.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2847 - 2847
12345